Virtual Sickle Cell Disease Policy Forum
The SCD Policy Forum brings together sickle cell advocates from across the country for a two-day federal advocacy event. This event is hosted by Sick Cells and the Sickle Cell…
Browse earlier OneSCDvoice reporting with its original publication date and source. Articles keep the URLs they had when first published.
8 articlespublished in 2024Current news
The SCD Policy Forum brings together sickle cell advocates from across the country for a two-day federal advocacy event. This event is hosted by Sick Cells and the Sickle Cell…
services & support
Welcome to the SCD C.A.R.E.S. (Collaboration of Advocates for Research, Education and Science) Consortium! The mission of this initiative is to raise awareness about the…
sickle cell disease · sickle cell · cell disease · sickle · cell · services & support · Clinical Trial Studies · Clinical Trials · How to Participate
Welcome to the Sickle Cell Disease Association of America’s Clinical Trial Finder, created in partnership with Forma Therapeutics. Our Clinical Trial Finder is a centralized…
Videos · Benefits of Trial Participation · Clinical Trial Studies · Clinical Trials
https://www.youtube.com/watch?v=iWqQiJeP5ac
infographics/slides
/sites/default/files/wp-content/uploads/2024/02/H-3734-SCD-Cares-Consortium-Journey-Flier-rev5_HI.png
sickle cell disease · sickle cell · cell disease · sickle · cell · Patient Education · Family Planning · Gene Therapy · Reproductive Health · Reproductive Issues/Complications · Women's Health
As we closed 2023, the Food and Drug Administration (FDA) approved two gene therapies to treat sickle cell disease (SCD). These potential curative therapies include CASGEVY™…
Happenings
SCDAA and MedicAlert Pilot Program Improving quality of life for people with sickle cell disease Sickle Cell Disease Association of America , Inc. (SCDAA) and MedicAlert…
Business
The US Food and Drug Administration (FDA) recently greenlit 2 cell-based gene treatments for sickle cell anemia, including the first therapy involving the genome editing…